Oral supplement enriched in HMB combined with pulmonary rehabilitation improves body composition and health related quality of life in patients with bronchiectasis (Prospective, Randomised Study).

Abstract

BACKGROUND & AIMS:

Pulmonary Rehabilitation (PR) is recommended for bronchiectasis but there is no data about its effect on body composition. The aim of this study is to assess the effect of Pulmonary Rehabilitation (PR) for 12 weeks in normally-nourished non-cystic-fibrosis bronchiectasis patients compared with the effect of PR plus a hyperproteic oral nutritional supplement enriched with beta-hydroxy-beta-methylbutyrate (HMB) on body composition, muscle strength, quality of life and serum biomarkers.

METHODS:

single center randomized controlled trial, parallel treatment design: Participants were randomly assigned to receive PR for 12 weeks or PR plus ONS (PRONS) (one can per day). Outcome assessments were performed at baseline, 12 weeks and 24 weeks: body composition (Dual-energy X-Ray Absorptiometry (DEXA), mid-arm muscle circumference (MAMC), phase angle by Bio-impedance), health related quality of life (Spanish QOL-B-V3.0, Physical Functioning Scale), handgrip strength, diet questionnaire, and plasma levels of prealbumin, myostatin and somatomedin-c.

RESULTS:

Thirty patients were randomized (15 per group) without differences in clinical and respiratory variables. In the PRONS group bone mineral density (BMD), mean and maximum handgrip dynamometry, MAMC, QOLB and prealbumin were significantly increased from baseline at 12 and 24 weeks and Fat free Mass (FFM) and FFM index, at 12 weeks. In the PR group only mean handgrip dynamometry and prealbumin were significantly increased at 12 and 24 weeks. In both groups plasma myostatin was reduced at 12 weeks (without significant differences).

CONCLUSION:

The addition of a hyperproteic ONS enriched with HMB to Pulmonary Rehabilitation could improve body composition, BMD, muscle strength and health related quality of life in bronchiectasis patients. Clinical Trials Number NCT02048397.

• Authors: Gabriel Olveira, Casilda Olveira, Esperanza Doña, Francisco Javier Palenque, Nuria Porras, Antonio Dorado, Ana M Godoy, Elehazara Rubio-Martínez, Gemma Rojo-Martínez, Rocío Martín-Valero
• Journal: Clinical nutrition (Edinburgh, Scotland) (Clin Nutr) Vol. 35 Issue 5 Pg. 1015-22 (10 2016) ISSN: 1532-1983 [Electronic] England
• PMID: 26522923 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Chemical References

• Biomarkers
• Myostatin
• Valerates
• beta-hydroxyisovaleric acid

Topics

• Adult
• Aged
• Biomarkers (blood)
• Body Composition
• Body Mass Index
• Bone Density
• Bronchiectasis (drug therapy, rehabilitation)
• Diet
• Dietary Supplements
• Electric Impedance
• Female
• Hand Strength
• Humans
• Male
• Middle Aged
• Muscle Strength (drug effects)
• Myostatin (blood)
• Prospective Studies
• Quality of Life
• Surveys and Questionnaires
• Treatment Outcome
• Valerates (administration & dosage)